BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int. 2011;2011:403929. [PMID: 21559202 DOI: 10.4061/2011/403929] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Pedrassa BC, da Rocha EL, Kierzenbaum ML, Bormann RL, Francisc VV, D'Ippolito G. Uncommon hepatic tumors: iconographic essay - Part 2. Radiol Bras 2014;47:374-9. [PMID: 25741121 DOI: 10.1590/0100-3984.2013.1761] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Peng WX, Wan YY, Gong AH, Ge L, Jin J, Xu M, Wu CY. Egr-1 regulates irradiation-induced autophagy through Atg4B to promote radioresistance in hepatocellular carcinoma cells. Oncogenesis 2017;6:e292. [PMID: 28134935 DOI: 10.1038/oncsis.2016.91] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
3 Joseph NM, Ferrell LD, Jain D, Torbenson MS, Wu TT, Yeh MM, Kakar S. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol 2014;27:62-72. [PMID: 23807780 DOI: 10.1038/modpathol.2013.114] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
4 Lim D, Lee SY, Lim KH, Chan CY. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. World J Gastroenterol 2013; 19(27): 4432-4436 [PMID: 23885159 DOI: 10.3748/wjg.v19.i27.4432] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
5 Karkar AM, Tang LH, Kashikar ND, Gonen M, Solomon SB, Dematteo RP, D’ Angelica MI, Correa-Gallego C, Jarnagin WR, Fong Y. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB (Oxford). 2013;15:235-243. [PMID: 23374365 DOI: 10.1111/j.1477-2574.2012.00584.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
6 Pedrassa BC, da Rocha EL, Kierszenbaum ML, Bormann RL, Torres LR, D'Ippolito G. Uncommon hepatic tumors: iconographic essay - Part 1. Radiol Bras 2014;47:310-6. [PMID: 25741106 DOI: 10.1590/0100-3984.2013.1760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gera S, Ettel M, Acosta-Gonzalez G, Xu R. Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. World J Hepatol 2017; 9(6): 300-309 [PMID: 28293379 DOI: 10.4254/wjh.v9.i6.300] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
8 Lee JI, Lee JW, Kim JM, Kim JK, Chung HJ, Kim YS. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers. World J Gastroenterol 2012; 18(34): 4751-4757 [PMID: 23002345 DOI: 10.3748/wjg.v18.i34.4751] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
9 Kuznietsova H, Dziubenko N, Herheliuk T, Prylutskyy Y, Tauscher E, Ritter U, Scharff P. Water-Soluble Pristine C60 Fullerene Inhibits Liver Alterations Associated with Hepatocellular Carcinoma in Rat. Pharmaceutics 2020;12:E794. [PMID: 32842595 DOI: 10.3390/pharmaceutics12090794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Xie F, Zhu F, Lu Z, Liu Z, Wang H. Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis. Oncol Lett 2016;12:495-503. [PMID: 27347171 DOI: 10.3892/ol.2016.4615] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Zhang Q, Shang L, Zang Y, Chen X, Zhang L, Wang Y, Wang L, Liu Y, Mao S, Shen Z. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation. Eur J Gastroenterol Hepatol 2014;26:544-52. [PMID: 24614696 DOI: 10.1097/MEG.0000000000000029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
12 Costa AF, Thipphavong S, Arnason T, Stueck AE, Clarke SE. Fat-Containing Liver Lesions on Imaging: Detection and Differential Diagnosis. AJR Am J Roentgenol 2018;210:68-77. [PMID: 29064755 DOI: 10.2214/AJR.17.18136] [Cited by in Crossref: 13] [Article Influence: 3.3] [Reference Citation Analysis]
13 Mallick S, Mallik M, Chatterjee RN, Chowdhury PS. Role of Cell Block Technology as an Adjunct to Fine Needle Aspiration in Evaluating as well as Differentiating Liver Lesions. Iran J Pathol 2021;16:392-402. [PMID: 34567188 DOI: 10.30699/IJP.20201.522897.2569] [Reference Citation Analysis]
14 Yamada HY, Zhang Y, Reddy A, Mohammed A, Lightfoot S, Dai W, Rao CV. Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice. Carcinogenesis. 2015;36:429-440. [PMID: 25740822 DOI: 10.1093/carcin/bgv011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
15 McInnes MD, Hibbert RM, Inácio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. Radiology 2015;277:413-23. [PMID: 26020440 DOI: 10.1148/radiol.2015142986] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 9.3] [Reference Citation Analysis]
16 Karadag Soylu N. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint. J Gastrointest Cancer 2020;51:1176-86. [PMID: 32844348 DOI: 10.1007/s12029-020-00499-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
17 Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, Snavely A, Rogers AB, Montgomery SA, Rathmell WK, McRee AJ. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointest Cancer 2015;5:61-71. [PMID: 25844041 DOI: 10.2147/GICTT.S72274] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Liu W, Delwaide J, Bletard N, Delvenne P, Meunier P, Hustinx R, Detry O. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World J Hepatol 2017; 9(11): 562-566 [PMID: 28469812 DOI: 10.4254/wjh.v9.i11.562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Torres-Mena JE, Salazar-Villegas KN, Sánchez-Rodríguez R, López-Gabiño B, Del Pozo-Yauner L, Arellanes-Robledo J, Villa-Treviño S, Gutiérrez-Nava MA, Pérez-Carreón JI. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC. Dig Dis Sci 2018;63:934-44. [PMID: 29383608 DOI: 10.1007/s10620-018-4943-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
20 Kinoshita M, Takemura S, Tanaka S, Hamano G, Ito T, Aota T, Koda M, Ohsawa M, Kubo S. Ruptured focal nodular hyperplasia observed during follow-up: a case report. Surg Case Rep 2017;3:44. [PMID: 28315131 DOI: 10.1186/s40792-017-0320-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Liu WC, Liu QY. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 6252-6261 [PMID: 24876746 DOI: 10.3748/wjg.v20.i20.6252] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
22 Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol. 2014;203:W408-W414. [PMID: 25055198 DOI: 10.2214/ajr.13.12251] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
23 Bamodu OA, Chang HL, Ong JR, Lee WH, Yeh CT, Tsai JT. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma. Cells 2020;9:E746. [PMID: 32197467 DOI: 10.3390/cells9030746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
24 Natu A, Singh A, Gupta S. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. World J Hepatol 2021; 13(11): 1568-1583 [DOI: 10.4254/wjh.v13.i11.1568] [Reference Citation Analysis]
25 Venkatesh SK, Chandan V, Roberts LR. Liver masses: a clinical, radiologic, and pathologic perspective. Clin Gastroenterol Hepatol. 2014;12:1414-1429. [PMID: 24055987 DOI: 10.1016/j.cgh.2013.09.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
26 Khemlina G, Ikeda S, Kurzrock R. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Mol Cancer. 2017;16:149. [PMID: 28854942 DOI: 10.1186/s12943-017-0712-x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 29.3] [Reference Citation Analysis]